Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of monthly intravenous ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment: The MONUMENT study.
Chiba K, Yamada S, Yoda I, Era M, Yokota K, Okazaki N, Ota S, Isobe Y, Miyazaki S, Tashiro S, Nakashima S, Morimoto S, Sato S, Tsukazaki T, Watanabe T, Enomoto H, Yabe Y, Yonekura A, Tomita M, Ito M, Osaki M. Chiba K, et al. Among authors: sato s. Bone. 2021 Mar;144:115770. doi: 10.1016/j.bone.2020.115770. Epub 2020 Nov 27. Bone. 2021. PMID: 33249321 Free article.
Effects of a trauma center on early mortality after trauma in a regional city in Japan: a population-based study.
Takahashi Y, Sato S, Yamashita K, Matsumoto N, Nozaki Y, Hirao T, Tajima G, Inokuma T, Yamano S, Takahashi K, Miyamoto T, Inoue K, Osaki M, Tasaki O. Takahashi Y, et al. Among authors: sato s. Trauma Surg Acute Care Open. 2019 Jun 2;4(1):e000291. doi: 10.1136/tsaco-2018-000291. eCollection 2019. Trauma Surg Acute Care Open. 2019. PMID: 31245618 Free PMC article.
Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT.
Iwamoto N, Sato S, Sumiyoshi R, Chiba K, Miyamoto N, Arinaga K, Kobayashi M, Yamamoto H, Osaki M, Kawakami A. Iwamoto N, et al. Among authors: sato s. Trials. 2019 Aug 13;20(1):494. doi: 10.1186/s13063-019-3589-8. Trials. 2019. PMID: 31409388 Free PMC article.
The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation, high-resolution, peripheral quantitative computed tomography (HR-pQCT).
Haraguchi A, Shigeno R, Horie I, Morimoto S, Ito A, Chiba K, Kawazoe Y, Tashiro S, Miyamoto J, Sato S, Yamamoto H, Osaki M, Kawakami A, Abiru N. Haraguchi A, et al. Among authors: sato s. Trials. 2020 May 5;21(1):379. doi: 10.1186/s13063-020-04276-4. Trials. 2020. PMID: 32370806 Free PMC article.
Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Shimizu T, Kawashiri SY, Sato S, Morimoto S, Minoda S, Kawazoe Y, Kuroda S, Tashiro S, Sumiyoshi R, Hosogaya N, Yamamoto H, Kawakami A. Shimizu T, et al. Among authors: sato s. Medicine (Baltimore). 2020 Aug 7;99(32):e21480. doi: 10.1097/MD.0000000000021480. Medicine (Baltimore). 2020. PMID: 32769882 Free PMC article.
Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound, and biomarker assessments.
Kawashiri SY, Shimizu T, Sato S, Morimoto S, Kawazoe Y, Sumiyoshi R, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Kawashiri SY, et al. Among authors: sato s. Medicine (Baltimore). 2020 Jul 24;99(30):e21151. doi: 10.1097/MD.0000000000021151. Medicine (Baltimore). 2020. PMID: 32791688 Free PMC article.
Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant).
Sumiyoshi R, Koga T, Shimizu T, Sato S, Tashiro S, Hosogaya N, Yamamoto H, Kawakami A. Sumiyoshi R, et al. Among authors: sato s. Medicine (Baltimore). 2020 Dec 11;99(50):e22708. doi: 10.1097/MD.0000000000022708. Medicine (Baltimore). 2020. PMID: 33327226 Free PMC article. Clinical Trial.
Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): A study protocol for an interventional, multicenter, open-label and single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Shimizu T, Kawashiri SY, Sato S, Kawazoe Y, Kuroda S, Kawasaki R, Ito Y, Morimoto S, Yamamoto H, Kawakami A. Shimizu T, et al. Among authors: sato s. Medicine (Baltimore). 2022 Jan 14;101(2):e28463. doi: 10.1097/MD.0000000000028463. Medicine (Baltimore). 2022. PMID: 35029189 Free PMC article.
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Chiba K, et al. Among authors: sato s. Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6. Bone. 2022. PMID: 35398293 Free article. Clinical Trial.
Corrigendum to "Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study" [Bone 160 (2022) 116416].
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Chiba K, et al. Among authors: sato s. Bone. 2022 Sep;162:116484. doi: 10.1016/j.bone.2022.116484. Epub 2022 Jul 1. Bone. 2022. PMID: 35785593 Free article. No abstract available.
11,951 results
You have reached the last available page of results. Please see the User Guide for more information.